Overcoming years of stalemate, the World Intellectual Property Organization (WIPO) agreed to negotiate a proposed treaty on genetic resources and related traditional knowledge (TK) that are key components in both traditional and new medicines. Delegates to WIPO’s General Assembly decided that the negotiations both to begin the draft international instrument and to conclude the talks […] Continue reading ->
Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading ->
The question of whether pathogens’ genomic sequences should be shared freely – or in exchange for a clear benefit – as well as the role ‘One Health’ should play in any new Pandemic Convention or legal accord were key points of emerging dispute among member states on Day 2 of the Intergovernmental Board Meeting (INB).  […] Continue reading ->
Major pharmaceutical companies have offered to reserve a “real-time allocation” of vaccines and treatments upfront for “priority populations in lower-income countries” in future pandemics – providing the G7 and G20 also help low-income countries finance and make effective use of the products. Launching its Berlin Declaration on Tuesday, the International Federation of Pharmaceutical Manufacturers and […] Continue reading ->